These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23385295)

  • 1. Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.
    Cross EM; Hare DJ
    J Inherit Metab Dis; 2013 Mar; 36(2):189-200. PubMed ID: 23385295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.
    Cross EM; Grant S; Jones S; Bigger BW; Wraith JE; Mahon LV; Lomax M; Hare DJ
    J Neurodev Disord; 2014; 6(1):46. PubMed ID: 25657821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.
    Barone R; Pellico A; Pittalà A; Gasperini S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):121. PubMed ID: 30442188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study.
    Hoffmann F; Hoffmann S; Kunzmann K; Ries M
    Orphanet J Rare Dis; 2020 Oct; 15(1):275. PubMed ID: 33008435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families.
    Malcolm C; Hain R; Gibson F; Adams S; Anderson G; Forbat L
    Acta Paediatr; 2012 Sep; 101(9):985-92. PubMed ID: 22452449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study.
    Nidiffer FD; Kelly TE
    J Ment Defic Res; 1983 Sep; 27 (Pt 3)():185-203. PubMed ID: 6415286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities.
    Hassiotis A; Hall I
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003406. PubMed ID: 15495051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with learning disabilities.
    Hassiotis AA; Hall I
    Cochrane Database Syst Rev; 2008 Jul; (3):CD003406. PubMed ID: 18677776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory and sleep disorders in mucopolysaccharidosis.
    Berger KI; Fagondes SC; Giugliani R; Hardy KA; Lee KS; McArdle C; Scarpa M; Tobin MJ; Ward SA; Rapoport DM
    J Inherit Metab Dis; 2013 Mar; 36(2):201-10. PubMed ID: 23151682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychobehavioral factors and family functioning in mucopolysaccharidosis: preliminary studies.
    do Valle DA; Bara TDS; Furlin V; Santos MLSF; Cordeiro ML
    Front Public Health; 2024; 12():1305878. PubMed ID: 38327584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioural training interventions for assisting foster carers in the management of difficult behaviour.
    Turner W; Macdonald GM; Dennis JA
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003760. PubMed ID: 15846680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses.
    Shapiro EG; Escolar ML; Delaney KA; Mitchell JJ
    Mol Genet Metab; 2017 Dec; 122S():8-16. PubMed ID: 29128371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature.
    Janzen D; Delaney KA; Shapiro EG
    Mol Genet Metab; 2017 Jun; 121(2):57-69. PubMed ID: 28506702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Functioning and Behaviour in Mucopolysaccharidosis IH [Hurlers Syndrome].
    Lehtonen A; Rust S; Jones S; Brown R; Hare D
    JIMD Rep; 2018; 39():75-81. PubMed ID: 28755358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical management of behavioral problems in mucopolysaccharidoses disorders.
    Escolar ML; Jones SA; Shapiro EG; Horovitz DDG; Lampe C; Amartino H
    Mol Genet Metab; 2017 Dec; 122S():35-40. PubMed ID: 29170079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of neurocognition in MPS disorders: A review.
    Shapiro EG; Eisengart JB
    Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating strategies to manage and endure challenging behaviors in mucopolysaccharidoses.
    Grant N
    Orphanet J Rare Dis; 2021 Apr; 16(1):165. PubMed ID: 33832528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviour in mucopolysaccharide disorders.
    Bax MC; Colville GA
    Arch Dis Child; 1995 Jul; 73(1):77-81. PubMed ID: 7639557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
    Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
    J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.